Abstract
We identified a somatic mutation in estrogen receptor-α (ERα) in breast cancer causing a lysine to arginine transition (K303R) resulting in hypersensitivity to estrogen, altered associations with coactivators and corepressors and altered posttranslational modifications of ERα. We have developed a transgenic mouse expressing the K303R mutant ERα under control of the mouse mammary tumor virus (MMTV) promoter. At 4 months of age, K303R ERα transgenic animals demonstrate precocious alveolar budding compared with wild-type ERα transgenic mice or nontransgenic littermates. Despite these morphologic differences, K303R ERα transgenic mice displayed no differences in levels of ERα, progesterone receptor or proliferation at this time-point. Pregnancy or chronic estrogen plus progesterone exposure in K303R ERα transgenic mice also resulted in significantly more alveolar budding, increased β-casein production and dilated ducts when compared with nontransgenic littermates. To examine the effects of mutant expression on tumorigenesis, mutant ERα mice were crossed with FVB-MMTVneu mice and significantly delayed time to neu-mediated tumorigenesis in bigenic animals. In contrast, mutant expression did not affect carcinogen-induced tumorigenesis. Collectively, these data demonstrate that aberrant estrogenic signaling through the K303R ERα mutation may lead to precocious alveolar budding in virgin mice, and to an expedited maturation and differentiation phenotype in the mammary glands of hormonally stimulated animals.
Similar content being viewed by others
References
Bershtein LM, Alimova IN, Tsyrlina EV, Anisimov VN . (2003). Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med 135: 580–581.
Bocchinfuso WP, Korach KS . (1997). Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2: 323–334.
Borras M, Hardy L, Lempereur F, el Khissiin AH, Legros N, Gol-Winkler R et al. (1994). Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48: 325–336.
Conway K, Parrish E, Edmiston SN, Tolbert D, Tse CK, Geradts J et al. (2005). The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study. Breast Cancer Res 7: R871–R880.
Cui Y, Niu A, Pestell R, Kumar R, Curran EM, Liu Y et al. (2006). Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 20: 2020–2035.
Cui Y, Zhang M, Pestell R, Curran EM, Welshons WV, Fuqua SA . (2004). Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity. Cancer Res 64: 9199–9208.
Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C et al. (2005). Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 117: 988–991.
Davies MP, O'Neill PA, Innes H, Sibson DR . (2005). Hypersensitive K303R oestrogen receptor-alpha variant not found in invasive carcinomas. Breast Cancer Res 7: R113–R118.
Durban EM, Medina D, Butel JS . (1985). Comparative analysis of casein synthesis during mammary cell differentiation in collagen and mammary gland development in vivo. Dev Biol 109: 288–298.
Frech MS, Halama ED, Tilli MT, Singh B, Gunther EJ, Chodosh LA et al. (2005). Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res 65: 681–685.
Fuqua SA, Wiltschke C, Zhang QX, Borg A, Castles CG, Friedrichs WE et al. (2000). A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 60: 4026–4029.
Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578–10582.
Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S . (1999). Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96: 2520–2525.
Herynk MH, Fuqua SA . (2004). Estrogen receptor mutations in human disease. Endocr Rev 25: 869–898.
Herynk MH, Parra I, Cui Y, Beyer A, Wu MF, Hilsenbeck SG et al. (2007). Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer. Clin Cancer Res 13: 3235–3243.
Ip MM, Asch BB . (2000). Methods in mammary gland biology and breast cancer research. Kluwer Academic/Plenum Publishers: New York, xvi, 329 p., [4] leaves of col. platespp.
Jin Z, MacDonald RS . (2002). Soy isoflavones increase latency of spontaneous mammary tumors in mice. J Nutr 132: 3186–3190.
Lavrovsky Y, Song CS, Chatterjee B, Roy AK . (1998). A rapid and reliable PCR-based assay for gene transmission and sex determination in newborn transgenic mice. Transgenic Res 7: 319–320.
Medina D . (1974). Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice. J Natl Cancer Inst 53: 213–221.
Medina D . (2004). Breast cancer: the protective effect of pregnancy. Clin Cancer Res 10: 380S–384S.
Mishra SK, Mazumdar A, Vadlamudi RK, Li F, Wang RA, Yu W et al. (2003). MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem 278: 19209–19219.
Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D . (2007). Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 9: R12.
Richert MM, Schwertfeger KL, Ryder JW, Anderson SM . (2000). An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 5: 227–241.
Russo J, Russo IH . (2004). Development of the human breast. Maturitas 49: 2–15.
Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L . (2005). Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol Endocrinol 19: 2671–2684.
Tekmal RR, Nair HB, Perla RP, Kirma N . (2007). HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis. J Steroid Biochem Mol Biol 106: 111–118.
Tilli MT, Frech MS, Steed ME, Hruska KS, Johnson MD, Flaws JA et al. (2003). Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma. Am J Pathol 163: 1713–1719.
Tokunaga E, Kimura Y, Maehara Y . (2004). No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas. Breast Cancer Res Treat 84: 289–292.
Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C et al. (2001). Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276: 18375–18383.
Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N et al. (2003). Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res 63: 2425–2433.
Acknowledgements
We thank Dr Gary Chamness for editorial assistance and Ms Robin Sample for administrative assistance. This work was supported by NIH/NCI CA72038 to SAWF, and by DAMD17-03-1-0417 to MHH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herynk, M., Lewis, M., Hopp, T. et al. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERα transgenic mice. Oncogene 28, 3177–3187 (2009). https://doi.org/10.1038/onc.2009.174
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.174
- Springer Nature Limited
Keywords
This article is cited by
-
G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression
Nature Communications (2016)
-
Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
Breast Cancer Research and Treatment (2014)